These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hypochlorite-oxidized LDL induces intraplatelet ROS formation and surface exposure of CD40L--a prominent role of CD36. Assinger A; Koller F; Schmid W; Zellner M; Koller E; Volf I Atherosclerosis; 2010 Nov; 213(1):129-34. PubMed ID: 20701912 [TBL] [Abstract][Full Text] [Related]
6. Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions. Yang M; Cooley BC; Li W; Chen Y; Vasquez-Vivar J; Scoggins NO; Cameron SJ; Morrell CN; Silverstein RL Blood; 2017 May; 129(21):2917-2927. PubMed ID: 28336528 [TBL] [Abstract][Full Text] [Related]
7. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo. Yang M; Kholmukhamedov A; Schulte ML; Cooley BC; Scoggins NO; Wood JP; Cameron SJ; Morrell CN; Jobe SM; Silverstein RL Blood Adv; 2018 Nov; 2(21):2848-2861. PubMed ID: 30381401 [TBL] [Abstract][Full Text] [Related]
8. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein. Chen K; Febbraio M; Li W; Silverstein RL Circ Res; 2008 Jun; 102(12):1512-9. PubMed ID: 18497330 [TBL] [Abstract][Full Text] [Related]
9. Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein. Nergiz-Unal R; Lamers MM; Van Kruchten R; Luiken JJ; Cosemans JM; Glatz JF; Kuijpers MJ; Heemskerk JW J Thromb Haemost; 2011 Sep; 9(9):1835-46. PubMed ID: 21696539 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM. Yu M; Jiang M; Chen Y; Zhang S; Zhang W; Yang X; Li X; Li Y; Duan S; Han J; Duan Y J Biol Chem; 2016 Aug; 291(33):16977-89. PubMed ID: 27358406 [TBL] [Abstract][Full Text] [Related]
11. Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects. Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Sawamura T; Gioffre WR; Auteri A; Puccetti L Clin Appl Thromb Hemost; 2005 Oct; 11(4):417-28. PubMed ID: 16244767 [TBL] [Abstract][Full Text] [Related]
12. Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36. Kar NS; Ashraf MZ; Valiyaveettil M; Podrez EA J Biol Chem; 2008 Mar; 283(13):8765-71. PubMed ID: 18245080 [TBL] [Abstract][Full Text] [Related]
13. CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding. Jay AG; Chen AN; Paz MA; Hung JP; Hamilton JA J Biol Chem; 2015 Feb; 290(8):4590-4603. PubMed ID: 25555908 [TBL] [Abstract][Full Text] [Related]
14. The effect of type 2 diabetes on CD36 expression and the uptake of oxLDL: Diabetes affects CD36 and oxLDL uptake. Kanoke A; Nishijima Y; Ljungberg M; Omodaka S; Yang SY; Wong S; Rabiller G; Tominaga T; Hsieh CL; Liu J Exp Neurol; 2020 Dec; 334():113461. PubMed ID: 32926860 [TBL] [Abstract][Full Text] [Related]
15. CD36 is a receptor for oxidized low density lipoprotein. Endemann G; Stanton LW; Madden KS; Bryant CM; White RT; Protter AA J Biol Chem; 1993 Jun; 268(16):11811-6. PubMed ID: 7685021 [TBL] [Abstract][Full Text] [Related]
16. Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain. Pearce SF; Roy P; Nicholson AC; Hajjar DP; Febbraio M; Silverstein RL J Biol Chem; 1998 Dec; 273(52):34875-81. PubMed ID: 9857015 [TBL] [Abstract][Full Text] [Related]
17. Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Love-Gregory L; Sherva R; Schappe T; Qi JS; McCrea J; Klein S; Connelly MA; Abumrad NA Hum Mol Genet; 2011 Jan; 20(1):193-201. PubMed ID: 20935172 [TBL] [Abstract][Full Text] [Related]
18. Diverse CD36 expression among Japanese population: defective CD36 mutations cause platelet and monocyte CD36 reductions in not only deficient but also normal phenotype subjects. Masuda Y; Tamura S; Matsuno K; Nagasawa A; Hayasaka K; Shimizu C; Moriyama T Thromb Res; 2015 May; 135(5):951-7. PubMed ID: 25798958 [TBL] [Abstract][Full Text] [Related]
19. Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation. Rios FJ; Koga MM; Ferracini M; Jancar S PLoS One; 2012; 7(5):e36632. PubMed ID: 22570732 [TBL] [Abstract][Full Text] [Related]
20. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. Han J; Hajjar DP; Febbraio M; Nicholson AC J Biol Chem; 1997 Aug; 272(34):21654-9. PubMed ID: 9261189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]